Sustainable Practices in Medicinal Chemistry: Current State and Future Directions

被引:175
作者
Bryan, Marian C. [1 ]
Dillon, Barry [2 ]
Hamann, Lawrence G. [3 ]
Hughes, Gregory J. [4 ]
Kopach, Michael E. [5 ]
Peterson, Emily A. [6 ]
Pourashraf, Mehrnaz [7 ]
Raheem, Izzat [8 ]
Richardson, Paul [9 ]
Richter, Daniel
Sneddon, Helen F. [10 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] AstraZeneca, Brixham Environm Lab, Brixham TQ5 8BA, Devon, England
[3] Novartis Inst BioMed Res, Cambridge, MA 02139 USA
[4] Merck, Rahway, NJ 07065 USA
[5] Eli Lilly & Co, Indianapolis, IN 46285 USA
[6] Amgen Inc, Cambridge, MA 02142 USA
[7] AstraZeneca, R&D Montreal, St Laurent, PQ H4S 1Z9, Canada
[8] Merck, West Point, PA 19486 USA
[9] Pfizer Global Res & Dev, San Diego, CA 92121 USA
[10] GlaxoSmithKline, Med Res Ctr, Stevenage SG1 2NY, Herts, England
关键词
GREEN CHEMISTRY; PHARMACEUTICAL-INDUSTRY; ENZYMATIC REDUCTION; ORGANIC-SYNTHESIS; ROOM-TEMPERATURE; CROSS-COUPLINGS; DRUG DISCOVERY; SOLVENT; REPLACEMENT; PERSPECTIVE;
D O I
10.1021/jm400250p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The medicinal chemistry subgroup of the American Chemical Society's Green Chemistry Institute Pharmaceutical Roundtable (ACS GCI PR) offers a perspective on the current state of environmentally sustainable practices in medicinal chemistry with the aim of sharing best practices more widely and highlighting some potential future developments.
引用
收藏
页码:6007 / 6021
页数:15
相关论文
共 61 条
[1]   Green chemistry tools to influence a medicinal chemistry and research chemistry based organisation [J].
Alfonsi, Kim ;
Colberg, Juan ;
Dunn, Peter J. ;
Fevig, Thomas ;
Jennings, Sandra ;
Johnson, Timothy A. ;
Kleine, H. Peter ;
Knight, Craig ;
Nagy, Mark A. ;
Perry, David A. ;
Stefaniak, Mark .
GREEN CHEMISTRY, 2008, 10 (01) :31-36
[2]  
Anastas P.T., 1998, Green chemistry: theory and practice
[3]  
[Anonymous], 2012, ACCOUNTS CHEM RES
[4]   Key green chemistry research areas - a perspective from pharmaceutical manufacturers [J].
Constable, David J. C. ;
Dunn, Peter J. ;
Hayler, John D. ;
Humphrey, Guy R. ;
Leazer, Johnnie L., Jr. ;
Linderman, Russell J. ;
Lorenz, Kurt ;
Manley, Julie ;
Pearlman, Bruce A. ;
Wells, Andrew ;
Zaks, Aleksey ;
Zhang, Tony Y. .
GREEN CHEMISTRY, 2007, 9 (05) :411-420
[5]   Perspective on solvent use in the pharmaceutical industry [J].
Constable, David J. C. ;
Jimenez-Gonzalez, Conchita ;
Henderson, Richard K. .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2007, 11 (01) :133-137
[6]  
Cooper G. S., 2011, TOXICOLOGICAL REV DI
[7]   Divergent C-H Functionalizations Directed by Sulfonamide Pharmacophores: Late-Stage Diversification as a Tool for Drug Discovery [J].
Dai, Hui-Xiong ;
Stepan, Antonia F. ;
Plummer, Mark S. ;
Zhang, Yang-Hui ;
Yu, Jin-Quan .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (18) :7222-7228
[8]   Catalytic C-H functionalization by metal carbenoid and nitrenoid insertion [J].
Davies, Huw M. L. ;
Manning, James R. .
NATURE, 2008, 451 (7177) :417-424
[9]  
Eames J, 2001, EUR J ORG CHEM, V2001, P1213
[10]   Optimisation of solvent replacement procedures according to economic and environmental criteria [J].
Elgue, S ;
Prat, L ;
Cabassud, M ;
Cézerac, J .
CHEMICAL ENGINEERING JOURNAL, 2006, 117 (02) :169-177